| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Canada | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Israel | 1 | |
| #7 | New Zealand | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Baird Andrew | 5 |
| #2 | Andreason Grai | 5 |
| #3 | Engler Robert L | 4 |
| #4 | Gao Mei Hua | 3 |
| #5 | Hickey Denise M | 1 |
| #6 | Kelly Tamsin L | 1 |
| #7 | Hammond H Kirk | 1 |
| #8 | Zhu Hong | 1 |
| #9 | Hsu Leigh J | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2005001133A2 | Compositions and methods for high throughput construction and functional analysis of expression libraries | |
| AU2004200697A1 | Variants of the Angiogenic Factor Vascular Endothelial Cell Growth Factor: VEGF | |
| AU1675102A | Dual recombinant gene therapy compositions and methods of use | |
| AU4321299A | Methods of altering cardiac cell phenotype | |
| AU2583399A | Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF |